Xcell Therapeutics Inc. (373110)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
1,370. 00
-9
-0.6526%
₩
66.18B Market Cap
- P/E Ratio
- Div Yield
162,930 Volume
- Eps
₩ 1,379
Previous Close Want to track 373110 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xcell Therapeutics Inc. (373110) Statistics
Valuation metrics
Market Cap 66.18B
Enterprise value 16.68B
Trailing P/E (ttm) -1.6
Forward P/E -
PEG ratio -0.12
Price/Sales (ttm) 6.59
Price/Book (mrq) 3.47
Enterprise Value/Revenue 6.31
Enterprise Value/EBITDA -2.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 80.1K
Average volume (90 days) 384.23K
Price summary
52-Week low 1,009
52-Week high 4,035
Beta -
50-Day moving average 1,179.66
200-Day moving average 1,419.88
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.15%
Operating margin -4.16%
Operational effectiveness
Return on assets -0.73%
Return on equity -2.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 152.7
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -633.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 365.57
Total debt (mrq) -
Total Debt/Equity (mrq) 0.81
Current ratio (mrq) 1.88%
Book value per share (mrq) 378.26
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
